Unveiling the in Vivo Protein Corona of Circulating Leukocyte-like Carriers
The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Abstract
Understanding interactions occurring at the interface between nanoparticles and biological components is an urgent challenge in nanomedicine due to their effect on the biological fate of nanoparticles. After the systemic injection of nanoparticles, a protein corona constructed by blood components surrounds the carrier's surface and modulates its pharmacokinetics and biodistribution. Biomimicry-based approaches in nanotechnology attempt to imitate what happens in nature in order to transfer specific natural functionalities to synthetic nanoparticles. Several biomimetic formulations have been developed, showing superior in vivo features as a result of their cell-like identity. We have recently designed biomimetic liposomes, called leukosomes, which recapitulate the ability of leukocytes to target inflamed endothelium and escape clearance by the immune system. To gain insight into the properties of leukosomes, we decided to investigate their protein corona in vivo. So far, most information about the protein corona has been obtained using in vitro experiments, which have been shown to minimally reproduce in vivo phenomena. Here we directly show a time-dependent quantitative and qualitative analysis of the protein corona adsorbed in vivo on leukosomes and control liposomes. We observed that leukosomes absorb fewer proteins than liposomes, and we identified a group of proteins specifically adsorbed on leukosomes. Moreover, we hypothesize that the presence of macrophage receptors on leukosomes' surface neutralizes their protein corona-meditated uptake by immune cells. This work unveils the protein corona of a biomimetic carrier and is one of the few studies on the corona performed in vivo.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“these strategies are still limited at conferring targeting specificity since an additional targeting ligand increases the propensity for protein corona formation to mask the targeting ability and inhibit the biological effects of nanoparticles18–24.”
From Cloaking nanoparticles with protein corona shield for targeted drug delivery. (2018) · cites this paper as [20]
In the citing paper
“suggesting that PCSN can increase their circulation time in the blood by decreasing the uptake from the immune system20.”
From Cloaking nanoparticles with protein corona shield for targeted drug delivery. (2018) · cites this paper as [20]
In the citing paper
“A critical but underexplored determinant of LNP biodistribution is the protein corona, the dynamic layer of plasma proteins adsorbed onto nanoparticle surfaces upon entry into the bloodstream, which fundamentally dictates receptor interactions, cellular uptake pathways, and organ-level distribution [20][21][22] .”
From High-density Lipoprotein Inspired Lipid Nanoparticles for Systemic RNA delivery to the Brain (2026) · cites this paper as [20]
Citations
Cites
Biomolecular coronas provide the biological identity of nanosized materials
Monopoli, M. P., Åberg, C., Salvati, A., & Dawson, K. A. (2012) · Nature Nanotechnology · doi:10.1038/nnano.2012.207 · Cited by 3,017
Lundqvist, M., Stigler, J., Elia, G., Lynch, I., Cedervall, T., & Dawson, K. A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805135105 · Cited by 2,823
Harrison’s Principles of Internal Medicine
Malani, P. N. (2012) · JAMA · doi:10.1001/jama.308.17.1813-b · Cited by 2,039
(2016) · CRC Press eBooks · doi:10.1201/b12801 · Cited by 2,031
Nanoparticle Size and Surface Chemistry Determine Serum Protein Adsorption and Macrophage Uptake
Walkey, C. D., Olsen, J. B., Guo, H., Emili, A., & Chan, W. C. W. (2012) · Journal of the American Chemical Society · doi:10.1021/ja2084338 · Cited by 1,926
Salvati, A., Pitek, A. S., Monopoli, M. P., Prapainop, K., Bombelli, F. B., Hristov, D. R., Kelly, P. M., Åberg, C., Mahon, E., & Dawson, K. A. (2013) · Nature Nanotechnology · doi:10.1038/nnano.2012.237 · Cited by 1,912
Monopoli, M. P., Walczyk, D., Campbell, A., Elia, G., Lynch, I., Baldelli Bombelli, F., & Dawson, K. A. (2011) · Journal of the American Chemical Society · doi:10.1021/ja107583h · Cited by 1,835
Walkey, C. D., & Chan, W. C. W. (2012) · Chem. Soc. Rev. · doi:10.1039/c1cs15233e · Cited by 1,758
Schöttler, S., Becker, G., Winzen, S., Steinbach, T., Mohr, K., Landfester, K., Mailänder, V., & Wurm, F. R. (2016) · Nature Nanotechnology · doi:10.1038/nnano.2015.330 · Cited by 1,272
Bio-inspired, bioengineered and biomimetic drug delivery carriers
Yoo, J.-W., Irvine, D. J., Discher, D. E., & Mitragotri, S. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3499 · Cited by 1,236
Research works printed but not linked: 2
- Langer R., 1998, Nature, 392, 5
- Lee H., 1985, J. Nucl. Med., 26, 72
Cited by
Dilliard, S. A., & Siegwart, D. J. (2023) · Nature Reviews Materials · doi:10.1038/s41578-022-00529-7 · Cited by 671
Cloaking nanoparticles with protein corona shield for targeted drug delivery.
Oh, J. Y., Kim, H. S., Palanikumar, L., Go, E. M., Jana, B., Park, S. A., Kim, H. Y., Kim, K., Seo, J. K., Kwak, S. K., et al. (2018) · Nature communications · doi:10.1038/s41467-018-06979-4 · Cited by 409
Rampado, R., Crotti, S., Caliceti, P., Pucciarelli, S., & Agostini, M. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00166 · Cited by 390
Ban, Z., Yuan, P., Yu, F., Peng, T., Zhou, Q., & Hu, X. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1919755117 · Cited by 313
“Unlike experiments alone (25, 27), a combination of integrated machine learning and experimentation supported the notion that corona functional compositions play a dominant role in mediating biomolecular recognition of NP – corona complexes (3, 39).”
BackgroundCell membrane biomimetic nanoparticles for inflammation and cancer targeting in drug delivery
Wang, H., Liu, Y., He, R., Xu, D., Zang, J., Weeranoppanant, N., Dong, H., & Li, Y. (2020) · Biomaterials Science · doi:10.1039/c9bm01392j · Cited by 297
Metadata
- Authors
- Corbo, C., Molinaro, R., Taraballi, F., Toledano Furman, N. E., Hartman, K. A., Sherman, M. B., De Rosa, E., Kirui, D. K., Salvatore, F., & Tasciotti, E.
- Affiliations
- CEINGE Biotecnologie Avanzate Franco Salvatore (Italy) (IT)
- Houston Methodist (US)
- The University of Texas Medical Branch at Galveston (US)
- Corresponding author
- Corbo, Claudia
- Tasciotti, Ennio
- ORCID
- Venue
- ACS Nano
- Publisher
- American Chemical Society (ACS)
- Published
- 2017-03-10
- Volume
- 11
- Issue
- 3
- Pages
- 3262-3273
- ISSN
- 1936-0851 (ISSN-L)
- 1936-086X
- OpenAlex
- W2592013183
- Cited by
- 155
- References
- 53
- Citations by year
- 2026: 11 · 2025: 14 · 2024: 5 · 2023: 22 · 2022: 20 · 2021: 17 · 2020: 26 · 2019: 17 · 2018: 16 · 2017: 7
- FWCI
- 6.49
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- ACS Nano (publishedVersion)
- PubMed (publishedVersion)
- BOA (University of Milano-Bicocca) (submittedVersion)
- CINECA IRIS Institutional Research information system (University of Urbino) (submittedVersion)
- Funders
- European Regional Development Fund
- Hearst Foundations (18130017)
- Ministero della Salute (RF-2010-2305526, RF-2010-2318372)
- Cancer Prevention and Research Institute of Texas (RP170466)
- European Social Fund
- Brown Foundation (18130011)
- Regione Campania
- Cullen Trust for Healthcare (18130014)
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Keywords
- protein corona, biomimetic liposomes, nanoparticle-biomolecule interactions, macrophage receptors, nanoparticle biodistribution, nanoparticle pharmacokinetics, nanomedicine
- MeSH terms
- Protein Corona, Adsorption, Animals, Cell Line, Liposomes, Mass Spectrometry, Microscopy, Confocal, Electrophoresis, Capillary, Cryoelectron Microscopy, Mice, Nanoparticles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Unveiling the in Vivo Protein Corona of Circulating Leukocyte-like Carriers. https://app.cochat.ai/papers/10.1021/acsnano.7b00376
- The paper
- Corbo, C., Molinaro, R., Taraballi, F., Toledano Furman, N. E., Hartman, K. A., Sherman, M. B., De Rosa, E., Kirui, D. K., Salvatore, F., & Tasciotti, E. (2017). Unveiling the in Vivo Protein Corona of Circulating Leukocyte-like Carriers. ACS Nano. https://doi.org/10.1021/acsnano.7b00376
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.